Evidence map›Paper›PMID 38909091›Full record

ArticleScientific reports2024

The landscape of the COVID-19 pandemic in Poland emerging from epidemiological and genomic data.

Barbara Mirska, Michal Zenczak, Katarzyna Nowis, Ireneusz Stolarek, Jan Podkowiński, Magdalena Rakoczy, Małgorzata Marcinkowska-Swojak, Natalia Koralewska, Paweł Zmora, Elżbieta Lenartowicz Onyekaa and 10 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in immunology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Barbara MirskaInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0001-7293-7183
Michal ZenczakInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0003-1539-4658
Katarzyna NowisInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0002-0415-0271
Ireneusz StolarekInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0002-1100-2138
Jan PodkowińskiInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0001-8376-9867
Magdalena RakoczyInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.
Małgorzata Marcinkowska-SwojakInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0001-8809-335X
Natalia KoralewskaInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0001-7096-0128
Paweł ZmoraInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0002-2012-7223
Elżbieta Lenartowicz OnyekaaInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0002-3596-4470
Marcin OsuchInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0003-4615-0189
Katarzyna ŁasińskaProvincial Sanitary and Epidemiology Station in Poznan, Poznan, Poland.
Jadwiga Kuczma-NapierałaProvincial Sanitary and Epidemiology Station in Poznan, Poznan, Poland.
Marcelina JaworskaBaptism of Poland Memorial Hospital, Gniezno, Poland.ORCID http://orcid.org/0000-0002-7229-6117
Łukasz MadejRegional Science and Technology Center, Podzamcze, Poland.ORCID http://orcid.org/0000-0002-4970-7598
Marzena CiechomskaNational Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.ORCID http://orcid.org/0000-0002-0961-6130
Aleksander JamsheerDepartment of Medical Genetics, Poznan University of Medical Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0003-4058-3901
Krzysztof KurowskiInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0002-4478-6119
Marek FiglerowiczInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland.ORCID http://orcid.org/0000-0002-6392-0192
Luiza HandschuhInstitute of Bioorganic Chemistry Polish Academy of Sciences, Poznan, Poland. luizahan@ibch.poznan.pl.ORCID http://orcid.org/0000-0001-9803-6877

Funding

Marshal of Wielkopolska RPWP.02.01.01-30-0001/20Ministry of Science and Higher Education in Poland 5536/E-63/SPUB/2017/1
6 · The paper itself

Abstract

The COVID-19 pandemic has profoundly affected all aspects of our lives. Through real-time monitoring and rapid vaccine implementation, we succeeded in suppressing the spread of the disease and mitigating its consequences. Finally, conclusions can be summarized and drawn. Here, we use the example of Poland, which was seriously affected by the pandemic. Compared to other countries, Poland has not achieved impressive results in either testing or vaccination, which may explain its high mortality (case fatality rate, CFR 1.94%). Through retrospective analysis of data collected by the COVID-19 Data Portal Poland, we found significant regional differences in the number of tests performed, number of cases detected, number of COVID-19-related deaths, and vaccination rates. The Masovian, Greater Poland, and Pomeranian voivodeships, the country's leaders in vaccination, reported high case numbers but low death rates. In contrast, the voivodeships in the eastern and southern parts of Poland (Subcarpathian, Podlaskie, Lublin, Opole), which documented low vaccination levels and low case numbers, had higher COVID-19-related mortality rates. The strong negative correlation between the CFR and the percentage of the population that was vaccinated in Poland supports the validity of vaccination. To gain insight into virus evolution, we sequenced more than 500 genomes and analyzed nearly 80 thousand SARS-CoV-2 genome sequences deposited in GISAID by Polish diagnostic centers. We showed that the SARS-CoV-2 variant distribution over time in Poland reflected that in Europe. Haplotype network analysis allowed us to follow the virus transmission routes and identify potential superspreaders in each pandemic wave.

Indexed as

COVID-19COVID-19 VaccinesPandemicsSARS-CoV-2Genome, ViralGenomicsHumansPolandRetrospective StudiesVaccinationCOVID-19 VaccinesCOVID-19EpidemiologyGenomicsHaplotype networkPandemicSARS-CoV-2

Identifiers

PMID38909091
PMCPMC11193717

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.